Market Cap 573.91M
Revenue (ttm) 1.12B
Net Income (ttm) 78.30M
EPS (ttm) N/A
PE Ratio 3.85
Forward PE 3.42
Profit Margin 6.97%
Debt to Equity Ratio -2.06
Volume 366,700
Avg Vol 621,406
Day's Range N/A - N/A
Shares Out 58.44M
Stochastic %K 80%
Beta 1.13
Analysts Sell
Price Target $17.75

Company Profile

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was fo...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 862 401 0000
Address:
300 Kimball Drive, Suite 300, Parsippany, United States
Thestocktraderhubzee
Thestocktraderhubzee May. 23 at 5:45 PM
$EMBC Mizuho Maintains Neutral on Embecta, Lowers Price Target to $13
0 · Reply
JarvisFlow
JarvisFlow May. 23 at 5:41 PM
Mizuho updates rating for Embecta ( $EMBC ) to Neutral, target set at 15 → 13.
0 · Reply
iruril
iruril May. 23 at 5:59 AM
$EMBC rebuying with increased size
0 · Reply
AlarmedSheiky
AlarmedSheiky May. 22 at 6:39 PM
$EMBC What the hell did they say in that conference that wiped away 20% of their value??
0 · Reply
d_risk
d_risk May. 9 at 4:47 PM
$EMBC - Embecta Corp. Common Stock - 10Q - Updated Risk Factors EMBC warns new trade actions, including tariffs and buy-local initiatives, could unexpectedly disrupt their business operations. #TradeRisk #SupplyChain #BusinessDisruption #Buy-localPolicies #TariffsImpact 🟢 Added 🟠 Removed https://d-risk.ai/EMBC/10-Q/2025-05-09
0 · Reply
DonCorleone77
DonCorleone77 May. 9 at 10:52 AM
$EMBC Embecta backs FY25 adjusted EPS view $2.70-$2.90, consensus $2.82 Lowers FY25 revenue view to $1.073B-$1.09B from $1.075B-$1.092B, consensus $1.09B.
0 · Reply
DonCorleone77
DonCorleone77 May. 9 at 10:51 AM
$EMBC Embecta reports Q2 adjusted EPS 70c, consensus 59c Reports Q2 revenue $259M, consensus $261.77M. "This quarter's financial results were once again slightly ahead of our prior expectations, as our teams executed well, which included driving an acceleration in our free-cash flow generation, thereby allowing us to continue to repay debt and create additional balance sheet flexibility," said Devdatt (Dev) Kurdikar, President and Chief Executive Officer of embecta. Kurdikar added, "In this challenging operating environment, we are raising key profitability metrics while maintaining our prior adjusted earnings per share guidance despite a lowered fiscal year 2025 adjusted constant current revenue guidance range and the impact of incremental tariffs. This reflects favorable projected foreign exchange rates, which are allowing us to keep our as-reported revenue guidance range largely unchanged, as well as disciplined operating expense controls and the benefit of our recently announced restructuring program."
0 · Reply
im_ichiban
im_ichiban May. 9 at 10:51 AM
$EMBC Embecta Corp. (NASDAQ: EMBC) reported Q2 EPS of $0.70, $0.17 better than the analyst estimate of $0.53. Revenue for the quarter came in at $259 million versus the consensus estimate of $253.86 million. GUIDANCE: Embecta Corp. sees FY2025 EPS of $2.70-$2.90, versus the consensus of $2.82. Embecta Corp. sees FY2025 revenue of $1.07-1.09 billion, versus the consensus of $1.09 billion. $0.15 quarter dividend $BBNX $DXCM $QDEL
0 · Reply
im_ichiban
im_ichiban May. 8 at 10:19 PM
$EMBC easy to see $17+ on good earning diabetes space hot $BBNX $DXCM $NVAX
1 · Reply
im_ichiban
im_ichiban May. 8 at 4:40 PM
$EMBC earning tomorrow $BBNX and $DXCM all good, diabetes hot!!!! $ABBV
0 · Reply
Latest News on EMBC
embecta to Participate in Investor Events

May 27, 2025, 5:00 PM EDT - 4 weeks ago

embecta to Participate in Investor Events


Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript

May 9, 2025, 1:39 PM EDT - 6 weeks ago

Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript


embecta Announces Quarterly Cash Dividend

May 9, 2025, 6:00 AM EDT - 6 weeks ago

embecta Announces Quarterly Cash Dividend


Embecta to host Analyst and Investor Day on May 22, 2025

Apr 28, 2025, 7:30 AM EDT - 2 months ago

Embecta to host Analyst and Investor Day on May 22, 2025


embecta to Report Fiscal Second Quarter 2025 Financial Results

Apr 21, 2025, 5:00 PM EDT - 2 months ago

embecta to Report Fiscal Second Quarter 2025 Financial Results


Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript

Feb 6, 2025, 1:55 PM EST - 4 months ago

Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript


embecta to Report Fiscal First Quarter 2025 Financial Results

Jan 23, 2025, 5:00 PM EST - 5 months ago

embecta to Report Fiscal First Quarter 2025 Financial Results


New Initiatives Expected To Make Embecta More Profitable

Dec 4, 2024, 8:30 AM EST - 7 months ago

New Initiatives Expected To Make Embecta More Profitable


Overlooked Stock: EMBC

Nov 27, 2024, 4:38 PM EST - 7 months ago

Overlooked Stock: EMBC


Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript

Nov 26, 2024, 2:04 PM EST - 7 months ago

Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript


Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript

Aug 9, 2024, 10:39 AM EDT - 11 months ago

Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript


embecta to Report Fiscal Third Quarter 2024 Financial Results

Jul 18, 2024, 5:00 PM EDT - 1 year ago

embecta to Report Fiscal Third Quarter 2024 Financial Results


Embecta (EMBC) CEO on Diabetes Treatment Market

May 17, 2024, 4:30 PM EDT - 1 year ago

Embecta (EMBC) CEO on Diabetes Treatment Market


Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript

May 11, 2024, 6:48 PM EDT - 1 year ago

Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript


Embecta Corp. (EMBC) Q1 2024 Earnings Call Transcript

Feb 9, 2024, 10:42 AM EST - 1 year ago

Embecta Corp. (EMBC) Q1 2024 Earnings Call Transcript


embecta to Report Fiscal First Quarter 2024 Financial Results

Jan 24, 2024, 5:00 PM EST - 1 year ago

embecta to Report Fiscal First Quarter 2024 Financial Results


embecta to Participate in Investor Conferences

Nov 29, 2023, 5:00 PM EST - 1 year ago

embecta to Participate in Investor Conferences


Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript

Nov 21, 2023, 4:19 PM EST - 1 year ago

Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript


Dividend Income Update September 2023

Oct 17, 2023, 8:30 PM EDT - 1 year ago

Dividend Income Update September 2023

ADM AFL ALLE AMGN AVGO BDX BP


Thestocktraderhubzee
Thestocktraderhubzee May. 23 at 5:45 PM
$EMBC Mizuho Maintains Neutral on Embecta, Lowers Price Target to $13
0 · Reply
JarvisFlow
JarvisFlow May. 23 at 5:41 PM
Mizuho updates rating for Embecta ( $EMBC ) to Neutral, target set at 15 → 13.
0 · Reply
iruril
iruril May. 23 at 5:59 AM
$EMBC rebuying with increased size
0 · Reply
AlarmedSheiky
AlarmedSheiky May. 22 at 6:39 PM
$EMBC What the hell did they say in that conference that wiped away 20% of their value??
0 · Reply
d_risk
d_risk May. 9 at 4:47 PM
$EMBC - Embecta Corp. Common Stock - 10Q - Updated Risk Factors EMBC warns new trade actions, including tariffs and buy-local initiatives, could unexpectedly disrupt their business operations. #TradeRisk #SupplyChain #BusinessDisruption #Buy-localPolicies #TariffsImpact 🟢 Added 🟠 Removed https://d-risk.ai/EMBC/10-Q/2025-05-09
0 · Reply
DonCorleone77
DonCorleone77 May. 9 at 10:52 AM
$EMBC Embecta backs FY25 adjusted EPS view $2.70-$2.90, consensus $2.82 Lowers FY25 revenue view to $1.073B-$1.09B from $1.075B-$1.092B, consensus $1.09B.
0 · Reply
DonCorleone77
DonCorleone77 May. 9 at 10:51 AM
$EMBC Embecta reports Q2 adjusted EPS 70c, consensus 59c Reports Q2 revenue $259M, consensus $261.77M. "This quarter's financial results were once again slightly ahead of our prior expectations, as our teams executed well, which included driving an acceleration in our free-cash flow generation, thereby allowing us to continue to repay debt and create additional balance sheet flexibility," said Devdatt (Dev) Kurdikar, President and Chief Executive Officer of embecta. Kurdikar added, "In this challenging operating environment, we are raising key profitability metrics while maintaining our prior adjusted earnings per share guidance despite a lowered fiscal year 2025 adjusted constant current revenue guidance range and the impact of incremental tariffs. This reflects favorable projected foreign exchange rates, which are allowing us to keep our as-reported revenue guidance range largely unchanged, as well as disciplined operating expense controls and the benefit of our recently announced restructuring program."
0 · Reply
im_ichiban
im_ichiban May. 9 at 10:51 AM
$EMBC Embecta Corp. (NASDAQ: EMBC) reported Q2 EPS of $0.70, $0.17 better than the analyst estimate of $0.53. Revenue for the quarter came in at $259 million versus the consensus estimate of $253.86 million. GUIDANCE: Embecta Corp. sees FY2025 EPS of $2.70-$2.90, versus the consensus of $2.82. Embecta Corp. sees FY2025 revenue of $1.07-1.09 billion, versus the consensus of $1.09 billion. $0.15 quarter dividend $BBNX $DXCM $QDEL
0 · Reply
im_ichiban
im_ichiban May. 8 at 10:19 PM
$EMBC easy to see $17+ on good earning diabetes space hot $BBNX $DXCM $NVAX
1 · Reply
im_ichiban
im_ichiban May. 8 at 4:40 PM
$EMBC earning tomorrow $BBNX and $DXCM all good, diabetes hot!!!! $ABBV
0 · Reply
im_ichiban
im_ichiban May. 8 at 12:44 PM
$EMBC should doing good this quarter, both $BBNX and $DXCM reported blowout earnings $NVAX
0 · Reply
JarvisFlow
JarvisFlow Apr. 10 at 11:31 AM
Mizuho has adjusted their stance on Embecta ( $EMBC ), setting the rating to Neutral with a target price of 15.
0 · Reply
EWSage
EWSage Mar. 31 at 5:33 PM
$EMBC could be a go to zero stock if the all time lows break, I can be wrong do what’s best for you
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 29 at 8:20 AM
$EMBC Digging EMBC's strategic pivot. Diabetes care market looking interesting. Their pen needle focus seems solid, might add small position. Watching how they navigate competitive landscape and restructuring. Potential long-term play in medical devices. great article: https://beyondspx.com/article/embecta-corp-embc-empowering-diabetes-care-through-innovation-and-expertise
0 · Reply
Avocado_smash
Avocado_smash Mar. 28 at 9:24 PM
$EMBC PT 12 and lower low.
0 · Reply
TechTraderAI
TechTraderAI Feb. 3 at 11:09 PM
Sold $EMBC (-2.7%). 43% long by 0% short. 18% long Technology, 7% long Consumer Discretionary, 7% long Finance, 7% long Industrials. https://www.techtrader.ai/wall/?date=1738616153&post=13847
0 · Reply
IsabellaDC
IsabellaDC Jan. 29 at 5:17 PM
Something to buy scan spat these out. No studies done, not a trading advice. $ATEN $TGNA $ACAD $EMBC $RLJ and so on.
0 · Reply
rottieluvr3
rottieluvr3 Dec. 31 at 9:53 PM
$EMBC Opened a position today. Feeling good about ‘25.
1 · Reply
Stoop_Kid
Stoop_Kid Dec. 21 at 4:29 AM
$EMBC $HG $ODD $ATAT Love these setups as well!
0 · Reply
vjtweet
vjtweet Dec. 19 at 3:18 PM
$EMBC another good one I got stopped out yesterday. No position now.
0 · Reply
d_risk
d_risk Dec. 11 at 11:40 PM
$EMBC - Embecta Corp. Common Stock - 10K - Updated Risk Factors Embecta's 2024 10-K risk factors reflect expanded competition, heightened reliance on pen needles and key distributors, increased geopolitical and ESG risks, broader pandemic concerns, and new internal control weaknesses, while trimming COVID-specific, IP, and separation-related disclosures. #Risk https://d-risk.ai/EMBC/10-K/2024-12-11
0 · Reply
vjtweet
vjtweet Dec. 11 at 4:03 AM
$EMBC another great looking setup for tomorrow.
0 · Reply